These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 23845918)

  • 1. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR; Kiser PF
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of vaginal or rectally applied microbicides in patients suffering from HIV/AIDS.
    Gupta SK; Nutan
    HIV AIDS (Auckl); 2013 Oct; 5():295-307. PubMed ID: 24174883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
    Hankins CA; Dybul MR
    Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical development of microbicides for the prevention of HIV infection.
    D'Cruz OJ; Uckun FM
    Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of topical antiretroviral chemoprophylaxis.
    Van Damme L; Szpir M
    Curr Opin HIV AIDS; 2012 Nov; 7(6):520-5. PubMed ID: 22918449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of dapivirine vaginal ring for HIV prevention.
    Devlin B; Nuttall J; Wilder S; Woodsong C; Rosenberg Z
    Antiviral Res; 2013 Dec; 100 Suppl():S3-8. PubMed ID: 24188702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbicides for prevention of HIV infection: clinical efficacy trials.
    Abdool Karim SS; Baxter C
    Curr Top Microbiol Immunol; 2014; 383():97-115. PubMed ID: 23695725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical development of microbicide drug products.
    Friend DR
    Pharm Dev Technol; 2010 Dec; 15(6):562-81. PubMed ID: 20017601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrospun fibers for vaginal anti-HIV drug delivery.
    Blakney AK; Ball C; Krogstad EA; Woodrow KA
    Antiviral Res; 2013 Dec; 100 Suppl():S9-16. PubMed ID: 24188701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.
    Notario-Pérez F; Ruiz-Caro R; Veiga-Ochoa MD
    Drug Des Devel Ther; 2017; 11():1767-1787. PubMed ID: 28670111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial.
    Sokal DC; Karim QA; Sibeko S; Yende-Zuma N; Mansoor LE; Baxter C; Grobler A; Frolich J; Kharsany AB; Miya N; Mlisana K; Maarshalk S; Karim SS
    Antivir Ther; 2013; 18(3):301-10. PubMed ID: 22914267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of antiretroviral prophylaxis for HIV prevention.
    García-Lerma JG; Heneine W
    Curr Opin HIV AIDS; 2012 Nov; 7(6):505-13. PubMed ID: 22964889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbicide dosage forms.
    Rohan LC; Devlin B; Yang H
    Curr Top Microbiol Immunol; 2014; 383():27-54. PubMed ID: 24220751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal microbicides and the prevention of HIV transmission.
    Cutler B; Justman J
    Lancet Infect Dis; 2008 Nov; 8(11):685-97. PubMed ID: 18992405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
    Adams JL; Kashuba AD
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug; 26(4):451-62. PubMed ID: 22306523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Vaginal Microbiome and its Potential to Impact Efficacy of HIV Pre-exposure Prophylaxis for Women.
    Velloza J; Heffron R
    Curr HIV/AIDS Rep; 2017 Oct; 14(5):153-160. PubMed ID: 28812207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of HIV prevention: prospects for an effective anti-HIV microbicide.
    Nuttall J; Romano J; Douville K; Galbreath C; Nel A; Heyward W; Mitchnick M; Walker S; Rosenberg Z
    Infect Dis Clin North Am; 2007 Mar; 21(1):219-39, x. PubMed ID: 17502237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.